T16	Exp 12 32	the kappa B enhancer
T17	Exp 36 74	the interleukin-2 receptor alpha chain
T18	Exp 117 141	the nuclear localization
T19	Exp 282 288	itself
T20	Exp 158 182	The two nuclear proteins
T21	Exp 235 258	the DNA-binding subunit
T22	Exp 354 365	the nucleus
T23	Exp 369 395	the human T-cell line IARC
T24	Exp 524 526	we
T25	Exp 454 459	which
T26	Exp 422 431	the roles
T27	Exp 468 494	the same kappa B enhancers
T28	Exp 435 452	these two factors
T29	Exp 652 664	their nuclei
T30	Exp 702 722	The kappa B enhancer
T31	Exp 726 734	the gene
T32	Exp 744 789	the interleukin-2 (IL-2) receptor alpha chain
T33	Exp 826 837	the hybrids
T34	Exp 974 980	itself
T35	Exp 889 893	that
T36	Exp 938 958	the kappa B enhancer
T37	Exp 869 883	These findings
T38	Exp 1000 1002	We
T39	Exp 1011 1015	that
T40	Exp 1074 1077	how
T41	Exp 1111 1135	the transient expression
T42	Exp 1173 1192	the immune response
T43	Exp 1078 1091	these factors
R5	Coref Anaphora:T19 Antecedent:T44
R6	Coref Anaphora:T25 Antecedent:T28
R7	Coref Anaphora:T29 Antecedent:T45
R8	Coref Anaphora:T34 Antecedent:T10
T1	Protein 40 68	interleukin-2 receptor alpha
T2	Protein 218 221	p50
T3	Protein 226 229	p65
T4	Protein 274 277	p50
T5	Protein 302 306	KBF1
T6	Protein 629 633	KBF1
T7	Protein 696 700	KBF1
T8	Protein 748 789	interleukin-2 (IL-2) receptor alpha chain
T9	Protein 791 802	IL-2R alpha
T10	Protein 966 970	KBF1
T11	Protein 1016 1020	KBF1
T12	Protein 1139 1143	IL-2
T13	Protein 1148 1159	IL-2R alpha
T44	Exp 262 272	NF-kappa B
T45	Exp 603 615	Most hybrids
